Scotia Capital’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $463K | Sell |
880
-3
| -0.3% | -$1.68K | ﹤0.01% | 710 |
|
|
2026
Q1 | $496K | Sell |
883
-2
| -0.2% | -$1.28K | ﹤0.01% | 678 |
|
|
2025
Q4 | $599K | Buy |
885
+109
| +14% | +$74.2K | ﹤0.01% | 630 |
|
|
2025
Q3 | $496K | Sell |
776
-139
| -15% | -$84.4K | ﹤0.01% | 668 |
|
|
2025
Q2 | $491K | Sell |
915
-178
| -16% | -$85.1K | ﹤0.01% | 629 |
|
|
2025
Q1 | $459K | Sell |
1,093
-126
| -10% | -$54.7K | ﹤0.01% | 630 |
|
|
2024
Q4 | $504K | Sell |
1,219
-13
| -1% | -$5.7K | ﹤0.01% | 619 |
|
|
2024
Q3 | $622K | Sell |
1,232
-31
| -2% | -$15.1K | ﹤0.01% | 584 |
|
|
2024
Q2 | $615K | Sell |
1,263
-11
| -0.9% | -$5.52K | ﹤0.01% | 570 |
|
|
2024
Q1 | $688K | Sell |
1,274
-13
| -1% | -$7.1K | ﹤0.01% | 551 |
|
|
2023
Q4 | $714K | Sell |
1,287
-6
| -0.5% | -$2.82K | ﹤0.01% | 517 |
|
|
2023
Q3 | $565K | Sell |
1,293
-42
| -3% | -$20.9K | ﹤0.01% | 543 |
|
|
2023
Q2 | $670K | Buy |
1,335
+13
| +1% | +$6.23K | ﹤0.01% | 504 |
|
|
2023
Q1 | $661K | Sell |
1,322
-11
| -0.8% | -$5.26K | ﹤0.01% | 506 |
|
|
2022
Q4 | $544K | Sell |
1,333
-125
| -9% | -$48.5K | ﹤0.01% | 545 |
|
|
2022
Q3 | $475K | Buy |
1,458
+15
| +1% | +$5.51K | ﹤0.01% | 566 |
|
|
2022
Q2 | $506K | Sell |
1,443
-35
| -2% | -$14.3K | ﹤0.01% | 571 |
|
|
2022
Q1 | $809K | Sell |
1,478
-1,178
| -44% | -$620K | 0.01% | 548 |
|
|
2021
Q4 | $1.75M | Buy |
2,656
+108
| +4% | +$67.8K | 0.01% | 430 |
|
|
2021
Q3 | $1.58M | Buy |
2,548
+117
| +5% | +$78.6K | 0.01% | 444 |
|
|
2021
Q2 | $1.53M | Buy |
2,431
+43
| +2% | +$23.7K | 0.01% | 432 |
|
|
2021
Q1 | $1.17M | Buy |
2,388
+315
| +15% | +$158K | 0.01% | 454 |
|
|
2020
Q4 | $1.04M | Buy |
2,073
+1,005
| +94% | +$450K | 0.01% | 437 |
|
|
2020
Q3 | $420K | Buy |
+1,068
| New | +$395K | ﹤0.01% | 538 |
|
|
2020
Q1 | – | Sell |
-1,637
| Closed | -$427K | – | 697 |
|
|
2019
Q4 | $427K | Sell |
1,637
-6,767
| -81% | -$1.78M | ﹤0.01% | 551 |
|
|
2019
Q3 | $2.29M | Buy |
8,404
+7,401
| +738% | +$2.06M | 0.03% | 261 |
|
|
2019
Q2 | $276K | Buy |
+1,003
| New | +$247K | ﹤0.01% | 623 |
|
|
2018
Q4 | – | Sell |
-10,480
| Closed | -$2.62M | – | 691 |
|
|
2018
Q3 | $2.62M | Buy |
10,480
+6,859
| +189% | +$1.66M | 0.03% | 259 |
|
|
2018
Q2 | $686K | Hold |
3,621
| – | – | 0.01% | 448 |
|
|
2018
Q1 | $693K | Sell |
3,621
-32
| -0.9% | -$5.91K | 0.01% | 458 |
|
|
2017
Q4 | $571K | Buy |
3,653
+176
| +5% | +$27.7K | 0.01% | 499 |
|
|
2017
Q3 | $540K | Buy |
3,477
+14
| +0.4% | +$2.21K | 0.01% | 500 |
|
|
2017
Q2 | $559K | Sell |
3,463
-11,723
| -77% | -$1.9M | 0.01% | 470 |
|
|
2017
Q1 | $2.35M | Buy |
+15,186
| New | +$2.09M | 0.04% | 241 |
|
Other funds holding IDXX
Scotia Capital's IDXX Position: Q2 2026 in Review
Scotia Capital reduced its Idexx Laboratories (IDXX) stake by 0.34% in Q2 2026, selling an estimated $1.68K and leaving 880 shares worth $463K. The position accounts for ﹤0.01% of the portfolio, ranked #710.
Scotia Capital first reported a position in IDXX in Q1 2017 and has held it in 34 quarters since. The position peaked at $2.62M in Q3 2018. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Scotia Capital held 880 shares of Idexx Laboratories worth $463K as of Q2 2026.
- Scotia Capital sold 3 Idexx Laboratories shares in Q2 2026, an estimated $1.68K.
- Idexx Laboratories made up ﹤0.01% of Scotia Capital's portfolio in Q2 2026, its #710 holding.
- Scotia Capital first reported a position in Idexx Laboratories in Q1 2017 and has held it in 34 quarters since.
- Scotia Capital's Idexx Laboratories position peaked at $2.62M in Q3 2018.
- 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Scotia Capital's 13F filing for Q2 2026, filed 11 Aug 2026.